Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

NCT02060604 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: Ketorolac + Ranibizumab
DRUG: Ranibizumab

Sponsor

Università degli Studi di Brescia